Skip to main content

Advertisement

Log in

Limitations in Controlling Risk for Recurrence After Curative Surgery for Advanced Gastric Cancer Are Now Well-Explained by Molecular-Based Mechanisms

  • Editorial
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev 2000;26:243–255.

    Google Scholar 

  2. Bonnenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908–914.

    Article  CAS  PubMed  Google Scholar 

  3. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical co-operation group. Br J Cancer 1999;79:1522–1530.

    Article  CAS  PubMed  Google Scholar 

  4. Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric-cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients. Br J Cancer 2001 (in press).

  5. Fujii M, Sasaki J, Nakajima T. State of the art in the treatment of gastric cancer: from the 71st Japanese gastric cancer congress. Gastric Cancer 1999;2:151–157.

    Google Scholar 

  6. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses. Cancer 2000;89:255–261.

    Article  CAS  PubMed  Google Scholar 

  7. Roukos DH. Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 2000; 7: 253–255, Editorial

    Google Scholar 

  8. InstitutionalAuthorNameThe Lancet (2000) ArticleTitleOveroptimism about cancer Lancet 355 157

    Google Scholar 

  9. Zippelius A, Pantel K. RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann N Y Acad Sci 2000;996:110–123.

    Google Scholar 

  10. Miyazono F, Natsugoe S, Takao S, et al. Surgical maneuvers enhance molecular detection of circulating tumor cells during gastric cancer surgery. Ann Surg 2001;233:189–194.

    Google Scholar 

  11. Gunduz N, Fisher B, Saffer EA. Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 1979;39:3861–3865.

    Google Scholar 

  12. Liotta L. Cancer: An attractive force in metastasis. Nature 2001;410:24–25.

    Article  Google Scholar 

  13. Eisenhauer EA. From the molecule to the clinic-inhibiting HER2 to treat breast cancer. NEJM 2001;344:841–842.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dimitrios H. Roukos MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roukos, D.H., Kappas, A.M. Limitations in Controlling Risk for Recurrence After Curative Surgery for Advanced Gastric Cancer Are Now Well-Explained by Molecular-Based Mechanisms. Ann Surg Oncol 8, 620–621 (2001). https://doi.org/10.1007/s10434-001-0620-5

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10434-001-0620-5

Navigation